Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B I Lord

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Cell and Tissue Kinetics|July 1, 1984
A comparison of low and high dose-rate radiation for recipient mice in spleen-colony studiesB I Lord, J H Hendry, J P Keene, et al.
Leukemia|December 22, 1999
Characterisation of the differential response of normal and CML haemopoietic progenitor cells to macrophage inflammatory protein-1alphaJ Dürig, N G Testa, B I Lord, et al.
Cytokine|January 1, 1992
Biological and structural properties of MIP-1 alpha expressed in yeastJ M Clements, S Craig, A J Gearing, et al.
International Journal of Radiation Biology|January 9, 1999
Induction of lympho-haemopoietic malignancy: impact of preconception paternal irradiationB I Lord, L B Woolford, L Wang, et al.
International Journal of Cancer|November 15, 1994
Haemopoietic progenitor and myeloid cell kinetics in humans treated with interleukin-3 and granulocyte/macrophage colony-stimulating factor in combinationB I Lord, N G Testa, S Bretti, et al.
British Journal of Cancer|August 14, 1998
Tumour induction by methyl-nitroso-urea following preconceptional paternal contamination with plutonium-239B I Lord, L B Woolford, L Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Clinical effects of human macrophage inflammatory protein-1 alpha MIP-1 alpha (LD78) administration to humans: a phase I study in cancer patients and normal healthy volunteers with the genetically engineered variant, BB-10010E Marshall, A H Howell, R Powles, et al.
Stem Cells (Dayton, Ohio)|December 1, 1998
CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitorsE A de Wynter, D Buck, C Hart, et al.
Blood|December 15, 1995
BB-10010: an active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical propertiesM G Hunter, L Bawden, D Brotherton, et al.
Blood|August 26, 1998
A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapyM J Clemons, E Marshall, J Dürig, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Cell and Tissue Kinetics|July 1, 1984
A comparison of low and high dose-rate radiation for recipient mice in spleen-colony studiesB I Lord, J H Hendry, J P Keene, et al.
Leukemia|December 22, 1999
Characterisation of the differential response of normal and CML haemopoietic progenitor cells to macrophage inflammatory protein-1alphaJ Dürig, N G Testa, B I Lord, et al.
Cytokine|January 1, 1992
Biological and structural properties of MIP-1 alpha expressed in yeastJ M Clements, S Craig, A J Gearing, et al.
International Journal of Radiation Biology|January 9, 1999
Induction of lympho-haemopoietic malignancy: impact of preconception paternal irradiationB I Lord, L B Woolford, L Wang, et al.
International Journal of Cancer|November 15, 1994
Haemopoietic progenitor and myeloid cell kinetics in humans treated with interleukin-3 and granulocyte/macrophage colony-stimulating factor in combinationB I Lord, N G Testa, S Bretti, et al.
British Journal of Cancer|August 14, 1998
Tumour induction by methyl-nitroso-urea following preconceptional paternal contamination with plutonium-239B I Lord, L B Woolford, L Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Clinical effects of human macrophage inflammatory protein-1 alpha MIP-1 alpha (LD78) administration to humans: a phase I study in cancer patients and normal healthy volunteers with the genetically engineered variant, BB-10010E Marshall, A H Howell, R Powles, et al.
Stem Cells (Dayton, Ohio)|December 1, 1998
CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitorsE A de Wynter, D Buck, C Hart, et al.
Blood|December 15, 1995
BB-10010: an active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical propertiesM G Hunter, L Bawden, D Brotherton, et al.
Blood|August 26, 1998
A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapyM J Clemons, E Marshall, J Dürig, et al.
Pageof 13